A Randomized Phase II Trial of Atezolizumab With or Without Bevacizumab in Cisplatin-ineligible Patients With Advanced/Unresectable Urothelial Cancer: Hoosier Cancer Research Network GU15-215
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 19 Jul 2018
At a glance
- Drugs Atezolizumab (Primary) ; Bevacizumab (Primary)
- Indications Urogenital cancer
- Focus Therapeutic Use
- Sponsors Roche
- 31 Aug 2018 Biomarkers information updated
- 12 Jul 2018 Status changed from recruiting to active, no longer recruiting.
- 26 Oct 2017 Status changed from not yet recruiting to recruiting.